Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.33 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.30 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28417275 | 1.00 | ADORA3 (0.33) | ADORA3SLC29A1KDM4EPKMADORA2A | |
| SCHEMBL28758954 | 0.86 | SLC29A1 (0.37) | ADORA3SLC29A1ADORA2AADORA2B | |
| SCHEMBL28521252 | 0.84 | HTR2C (0.31) | KDM4EPKM | |
| SCHEMBL31192291 | 0.84 | HTR2C (0.31) | KDM4EPKM | |
| SCHEMBL29407144 | 0.80 | KDM4E (0.31) | KDM4EPKM | |
| SCHEMBL29043762 | 0.80 | KDM4E (0.31) | KDM4EPKM | |
| SCHEMBL26090156 | 0.74 | HTR2B (0.35) | ADORA3KDM4EPKMADORA1 | |
| SCHEMBL29413061 | 0.74 | HTR2B (0.35) | ADORA3KDM4EPKMADORA1 | |
| SCHEMBL28660589 | 0.73 | LMNA (0.33) | ADORA3SLC29A1ADORA2AADORA1 | |
| SCHEMBL31406536 | 0.69 | ADORA2A (0.36) | ADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119604304-A | Recombinant RNA molecules comprising an untranslated region or a segment encoding spike protein from the Severe acute respiratory coronavirus 2 Omikovia strain | 葛兰素史克生物有限公司 | 2025-03-11 | — | — | CN | disclosed |